Sofinnova Investments Co-Investors 2026

Who Sofinnova Investments invests alongside: Alexandria Venture Investments, ARCH Venture Partners.

Sofinnova Investments accounts for 21 tracked companies with verified cap-table data, 21 of which disclose round sizes totalling $3.7B. The median disclosed raise is $157M, and the largest is Avenzo Therapeutics at $446M, ahead of Seaport Therapeutics ($330M) and BIOAGE LABS ($300M).

The names that recur most often on these co-invested cap tables are Sofinnova Investments (21 companies), OrbiMed (5 companies), Omega Funds (4 companies), Surveyor Capital (4 companies), Foresite Capital (3 companies), Third Rock Ventures (3 companies). By latest disclosed round, the market skews Series A (7), Series B (6), Series D (3), Series C (3).

Best funded Sofinnova Investments companies

  1. Avenzo Therapeutics — $446M (latest: Series A)
  2. Seaport Therapeutics — $330M (latest: Series A)
  3. BIOAGE LABS — $300M (latest: Series D)
  4. ARTBIO — $245M (latest: Series B)
  5. Aiolos Bio — $245M (latest: Series A)
  6. VelosBio — $213M (latest: Seed)
  7. Marea Therapeutics — $190M (latest: Series B)
  8. Visen Pharmaceuticals — $190M (latest: Series B)
  9. Expedition Therapeutics — $165M (latest: Series A)
  10. Alkeus Pharmaceuticals — $160M (latest: Series B)
  11. Axonis Therapeutics — $157M (latest: Series A)
  12. Gyroscope Therapeutics — $148M (latest: Series C)
  13. Shape Therapeutics — $147M (latest: Series B)
  14. Quanta Therapeutics — $142M (latest: Series D)
  15. OnCusp Therapeutics — $139M

Sofinnova Investments, Inc. — related firms and companies (56)

Sofinnova Investments, Inc. profile · All research reports